C CG Oncology, Inc.: insider trades · United States · SEC (Form 4) Discover the full insider trade history of CG Oncology, Inc., a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €4.9bn. The latest transaction was disclosed on 13 January 2026 (Levée d'options). Among the most active insiders: POST LEONARD E. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 13 January 2026
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
◇ Director · Executives · 9 Jan 2026
654 shares @ US$3.72 0.2% of flow Common Stock SEC:0001193125-26-011756:0
▼ Director · Executives · 9 Jan 2026
654 shares @ US$44.16 2.3% of flow Common Stock SEC:0001193125-26-011756:1
◇ Director · Executives · 9 Jan 2026
10,491 shares @ US$12.59 10.7% of flow Common Stock SEC:0001193125-26-011756:2
▼ Director · Executives · 9 Jan 2026
10,491 shares @ US$52.99 44.9% of flow Common Stock SEC:0001193125-26-011756:3
◇ Director · Executives · 29 Sept 2025
12,755 shares @ US$1.82 1.9% of flow Common Stock SEC:0001193125-25-225133:0
▼ Director · Executives · 29 Sept 2025
12,755 shares @ US$39.19 40.1% of flow Common Stock SEC:0001193125-25-225133:1
◇ Director · Executives · 21 May 2025
1,000 shares @ US$0.60 13.6% of flow Common Stock SEC:0000950170-25-076339:0
◇ Director · Executives · 28 Apr 2025
1,000 shares @ US$0.60 13.5% of flow Common Stock SEC:0000950170-25-060145:0
◇ Director · Executives · 17 Mar 2025
1,000 shares @ US$0.60 14.1% of flow Common Stock SEC:0000950170-25-041265:0
◇ Director · Executives · 18 Feb 2025
1,000 shares @ US$0.60 14.7% of flow Common Stock SEC:0000950170-25-023182:0
◇ Director · Executives · 13 Jan 2025
1,000 shares @ US$0.60 15.0% of flow Common Stock SEC:0000950170-25-005359:0
▼ Director · Executives · 16 Dec 2024
700,000 shares @ US$28.00 57.9% of flow Common Stock SEC:0001415889-24-029664:0
◇ Director · Executives · 16 Dec 2024
1,000 shares @ US$0.60 14.6% of flow Common Stock SEC:0000950170-24-137319:0
◇ Director · Executives · 6 Dec 2024
1,000 shares @ US$0.60 14.5% of flow Common Stock SEC:0000950170-24-134261:0
▼ Director · Executives · 29 Aug 2024
424,210 shares @ US$35.36 42.1% of flow Common Stock SEC:0000950170-24-102496:0
400,000 shares @ US$19.00 100.0% of flow Common Stock SEC:0001415889-24-010609:0
Ideal exit: 25 Oct 2024 (T+270) ▲ Chief Medical Officer · Executives · 29 Jan 2024
1,315 shares @ US$19.00 100.0% of flow Common Stock SEC:0000950170-24-009435:0
Ideal exit: 25 Oct 2024 (T+270) 3,628,198 shares Common Stock SEC:0001415889-24-002062:0
▲ CFO & Secretary · Executives · 29 Jan 2024
2,000 shares @ US$19.00 100.0% of flow Common Stock SEC:0000950170-24-009432:0
Ideal exit: 25 Oct 2024 (T+270) ● Director · Executives · 29 Jan 2024
350,771 shares Common Stock SEC:0000950170-24-009429:0